These are assumed to be the first in-vivo data showing that SIRT1 overexpression can suppress tumor formation and growth. These data are the work of Sirtris scientific advisory board co-chairs Sinclair and Leonard Guarente, the Novartis professor of biology at the Massachusetts Institute of Technology.